VanEck Associates’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.5M Sell
877,192
-556,407
-39% -$7.95M 0.01% 424
2025
Q1
$15.1M Buy
1,433,599
+488,621
+52% +$5.13M 0.02% 371
2024
Q4
$11.4M Buy
944,978
+36,239
+4% +$439K 0.01% 430
2024
Q3
$11.4M Sell
908,739
-143,593
-14% -$1.8M 0.01% 418
2024
Q2
$15.2M Sell
1,052,332
-107,479
-9% -$1.55M 0.02% 328
2024
Q1
$18.9M Sell
1,159,811
-211,228
-15% -$3.44M 0.03% 287
2023
Q4
$20.4M Sell
1,371,039
-249,603
-15% -$3.72M 0.04% 237
2023
Q3
$18.2M Sell
1,620,642
-89,661
-5% -$1.01M 0.04% 253
2023
Q2
$17.2M Buy
1,710,303
+321,238
+23% +$3.23M 0.04% 270
2023
Q1
$13.1M Sell
1,389,065
-268,476
-16% -$2.52M 0.03% 298
2022
Q4
$20.3M Buy
1,657,541
+217,344
+15% +$2.66M 0.05% 239
2022
Q3
$17.9M Sell
1,440,197
-475,506
-25% -$5.9M 0.05% 238
2022
Q2
$37.6M Buy
1,915,703
+541,538
+39% +$10.6M 0.1% 181
2022
Q1
$35.9M Buy
1,374,165
+292,157
+27% +$7.62M 0.07% 198
2021
Q4
$30.7M Buy
1,082,008
+83,607
+8% +$2.37M 0.07% 211
2021
Q3
$31.8M Buy
998,401
+68,435
+7% +$2.18M 0.08% 205
2021
Q2
$32.3M Buy
929,966
+24,052
+3% +$834K 0.08% 205
2021
Q1
$26.7M Buy
905,914
+381,731
+73% +$11.2M 0.07% 200
2020
Q4
$16.1M Sell
524,183
-56,617
-10% -$1.74M 0.05% 230
2020
Q3
$16.2M Sell
580,800
-232,914
-29% -$6.51M 0.05% 205
2020
Q2
$17.5M Buy
813,714
+88,360
+12% +$1.9M 0.06% 193
2020
Q1
$16.2M Buy
725,354
+51,010
+8% +$1.14M 0.08% 161
2019
Q4
$19.9M Buy
674,344
+41,064
+6% +$1.21M 0.08% 175
2019
Q3
$16.8M Sell
633,280
-30,632
-5% -$815K 0.08% 176
2019
Q2
$22.4M Buy
663,912
+469,050
+241% +$15.9M 0.11% 163
2019
Q1
$6.25M Sell
194,862
-12,459
-6% -$400K 0.03% 282
2018
Q4
$6.54M Buy
+207,321
New +$6.54M 0.03% 268